Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Decision making at the cellular level

26.06.2002


It’s a wonder cells make it through the day with the barrage of cues and messages they receive and transmit to direct the most basic and necessary functions of life. Such cell communication, or signal transduction, was at least thought to be an "automatic" cascade of biochemical events.



Now, however, a study reported in a recent issue of Nature by Johns Hopkins and Harvard scientists has found that even before a message makes it through the outer cell membrane to the inner nucleus, the cell is busy activating a molecular switch to guide how the message will be delivered in the first place.

"Our results add a layer of complexity to understanding how messages are communicated by cells," says Mark Donowitz, M.D., professor of medicine at Hopkins and a co-author of the study in the June 20 issue. "But by the same token, the new layer offers an exciting new aspect of cellular circuitry that could lead to potential therapies for many serious disorders," he says.


"This extra step in cell signaling actually lets the cell figure out how it’s going to communicate what it needs to," says Donowitz. "Without this switchboard system, the cell would go crazy and overload because every stimulus that passed by would be forwarded to its interior."

The two most common cellular signals are calcium and cyclic adenosine monophosphate, or cAMP. They are sometimes known as "second messengers" because they intercept messages from receptors on the cell surface and relay them to proteins within the cell, altering their shape and thus their behavior and that of the cell at large.

Donowitz and colleagues showed that a cell decides which signal to use, calcium or cAMP, by the presence or absence of a specific protein called sodium/hydrogen exchanger regulatory factor 2, or NHERF2. Specifically, their experiments tested how the receptor for parathyroid hormone, and for parathyroid hormone-related protein (also a hormone), on the cell surface signals the interior of the cell to perform specific functions.

They found that the signal includes more than just the receptor and the proteins that latch onto it, but requires an additional class of proteins (of which NHERF2 is a member) called PDZ proteins that determine whether to send the signal via calcium or through cAMP. If NHERF2 is present along with the parathyroid hormone receptor, then the signal is sent via calcium. If there is no NHERF2, then cAMP is responsible for delivering the message.

The cell’s decision to use calcium or cAMP is important because each generates different responses from its target proteins, says Donowitz. For example, a signal relayed by cAMP might induce a kidney cell to release water or a bone cell to break down into its constituent minerals. Likewise, signals relayed by calcium could lead to the aggregation of blood platelets, which cause clots, or to the release of histamine, a major component of the allergic response.

"These results show that at the very earliest stage of cell signaling, called receptor binding, there is a switch that determines what kind of signal will be used," says Donowitz. "To understand cell signaling, you really have to know the whole system."

The receptor for parathyroid hormone, for example, is crucial for signaling and proper functioning of the parathyroid glands, intestinal cells and kidney cells. Parathyroid hormone and parathyroid hormone-related protein are vital to the normal functioning of the body. Disruptions in the regulation or amount of these substances can lead to serious ailments, including kidney stones, convulsions, decalcification of bones or "rubber bones," and can interfere with the normal growth of bones and cartilage. Common diseases that are caused in part by faulty signaling in cells include cancer, diabetes and disorders of the immune system.


Other authors of the study are C. Chris Yun of Hopkins, Matthew J. Mahon (lead author) and Gino V. Segre (senior author), both of Massachusetts General Hospital and Harvard Medical School.

M.J. Mahon, et al. Nature (2002) Na+/H+ exchanger regulatory factor 2 directs parathyroid hormone 1 receptor signalling. Vol. 417:858-861.

Trent Stockton | EurekAlert!
Further information:
http://www.hopkinsmedicine.org/graduateprograms/cmm/donowitz.html

More articles from Life Sciences:

nachricht Molecular Force Sensors
20.09.2017 | Max-Planck-Institut für Biochemie

nachricht Foster tadpoles trigger parental instinct in poison frogs
20.09.2017 | Veterinärmedizinische Universität Wien

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

Im Focus: Silencing bacteria

HZI researchers pave the way for new agents that render hospital pathogens mute

Pathogenic bacteria are becoming resistant to common antibiotics to an ever increasing degree. One of the most difficult germs is Pseudomonas aeruginosa, a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Molecular Force Sensors

20.09.2017 | Life Sciences

Producing electricity during flight

20.09.2017 | Power and Electrical Engineering

Tiny lasers from a gallery of whispers

20.09.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>